Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	888	1,078	809	128	54	63
Market Cap Growth	-22.98%	33.36%	530.17%	138.82%	-14.69%	-6.71%
Enterprise Value	873.25	1,064	792.43	116.23	31.57	36.49
Last Close Price	22.88	27.54	21.35	3.49	1.47	1.92
PE Ratio	438.90	578.36	-	-	-	-
Forward PE	101.35	80.23	-	-	-	-
PS Ratio	7.67	9.30	10.51	3.82	2.99	4.56
PB Ratio	13.25	16.08	13.89	2.26	0.78	0.82
P/TBV Ratio	21.72	26.15	29.78	6.82	2.29	2.74
P/FCF Ratio	-	-	388.14	-	-	-
P/OCF Ratio	-	-	252.84	-	-	-
EV/Sales Ratio	7.54	9.18	10.30	3.46	1.76	2.64
EV/EBITDA Ratio	87.46	108.79	-	-	-	-
EV/EBIT Ratio	120.41	149.78	-	-	-	-
EV/FCF Ratio	-	-	380.42	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.02	0.02
Debt / EBITDA Ratio	0.11	0.11	-	-	-	-
Debt / FCF Ratio	-	-	0.85	-	-	-
Net Debt / Equity Ratio	-0.22	-0.22	-0.28	-0.21	-0.32	-0.34
Net Debt / EBITDA Ratio	-1.49	-1.49	6.69	1.76	2.09	4.50
Net Debt / FCF Ratio	6.35	6.35	-7.72	1.32	2.86	4.59
Asset Turnover	1.29	1.29	0.96	0.46	0.20	0.15
Inventory Turnover	1.17	1.17	1.89	2.49	2.91	2.32
Quick Ratio	1.42	1.42	1.63	2.22	2.20	2.72
Current Ratio	1.96	1.96	2.14	2.77	2.49	2.91
Return on Equity (ROE)	3.31%	3.31%	-6.35%	-17.02%	-19.87%	-9.26%
Return on Assets (ROA)	3.88%	3.88%	-7.04%	-13.61%	-13.98%	-7.40%
Return on Invested Capital (ROIC)	6.65%	7.80%	-12.54%	-22.94%	-25.07%	-12.59%
Return on Capital Employed (ROCE)	11.08%	11.08%	-7.87%	-15.31%	-17.75%	-10.20%
Earnings Yield	0.23%	0.17%	-	-	-	-
FCF Yield	-	-	0.26%	-	-	-
Buyback Yield / Dilution	-11.26%	-11.26%	-1.69%	-7.91%	-3.37%	-34.86%
Total Shareholder Return	-11.26%	-11.26%	-1.69%	-7.91%	-3.37%	-34.86%